Evidence map›Paper›PMID 35566907›Full record

ArticlePolymers2022

Application of Fungal Biomass for the Development of New Polylactic Acid-Based Biocomposites.

Mohammadtaghi Asadollahzadeh, Amir Mahboubi, Mohammad J Taherzadeh, Dan Åkesson, Patrik R Lennartsson

Abstract read
In one paragraph

Article in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Mycobiology · 2025
    Article
  3. Article
  4. Article
  5. Sustained Release of Hydrogen Sulfide from Di(ACS agricultural science & technology · 2022
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohammadtaghi AsadollahzadehSwedish Centre for Resource Recovery, University of Borås, 501 90 Borås, Sweden.ORCID 0000-0001-6123-4482
Amir MahboubiSwedish Centre for Resource Recovery, University of Borås, 501 90 Borås, Sweden.ORCID 0000-0001-6280-4483
Mohammad J TaherzadehSwedish Centre for Resource Recovery, University of Borås, 501 90 Borås, Sweden.ORCID 0000-0003-4887-2433
Dan ÅkessonSwedish Centre for Resource Recovery, University of Borås, 501 90 Borås, Sweden.
Patrik R LennartssonSwedish Centre for Resource Recovery, University of Borås, 501 90 Borås, Sweden.ORCID 0000-0003-3418-1762

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungal biomass (FB), a by-product of the fermentation processes produced in large volumes, is a promising biomaterial that can be incorporated into poly(lactic acid) (PLA) to develop enhanced biocomposites that fully comply with the biobased circular economy concept. The PLA/FB composites, with the addition of triethyl citrate (TEC) as a biobased plasticizer, were fabricated by a microcompounder at 150 °C followed by injection molding. The effects of FB (10 and 20 wt %) and TEC (5, 10, and 15 wt %) contents on the mechanical, thermal and surface properties of the biocomposites were analyzed by several techniques. The PLA/FB/TEC composites showed a rough surface in their fracture section. A progressive decrease in tensile strength and Young's modulus was observed with increasing FB and TEC, while elongation at break and impact strength started to increase. The neat PLA and biocomposite containing 10% FB and 15% TEC exhibited the lowest (3.84%) and highest (224%) elongation at break, respectively. For all blends containing FB, the glass transition, crystallization and melting temperatures were shifted toward lower values compared to the neat PLA. The incorporation of FB to PLA thus offers the possibility to overcome one of the main drawbacks of PLA, which is brittleness.

Indexed as

biocompositebiopolymersbrittlenessfungal biomass (FB)poly(lactic acid) (PLA)triethyl citrate (TEC)

Identifiers

PMID35566907
PMCPMC9100248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.